These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3365924)

  • 41. Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis.
    Aimin C; Chunlin H; Juliang B; Tinyin Z; Zhichao D
    Clin Orthop Relat Res; 1999 Sep; (366):239-47. PubMed ID: 10627741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels.
    Locksmith GJ; Chin A; Vu T; Shattuck KE; Hankins GD
    Obstet Gynecol; 2005 Mar; 105(3):473-9. PubMed ID: 15738010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
    Metz DC; Devlin JW; Vakily M; Atkinson S; Lloyd E
    Pharmacotherapy; 2008 Mar; 28(3):301-7. PubMed ID: 18294109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of four intravenous infusion methods on tobramycin pharmacokinetics.
    Pleasants RA; Sawyer WT; Williams DM; McKenna WR; Powell JR
    Clin Pharm; 1988 May; 7(5):374-9. PubMed ID: 3383543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline.
    Kanthawatana S; Uruwannakul K; Chotinarumon S
    J Med Assoc Thai; 1998 Feb; 81(2):136-40. PubMed ID: 9529844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gentamicin effects on urinary electrolyte excretion in healthy subjects.
    Elliott C; Newman N; Madan A
    Clin Pharmacol Ther; 2000 Jan; 67(1):16-21. PubMed ID: 10668849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-dependent pharmacokinetics of gentamicin in sheep.
    Brown SA; Coppoc GL; Riviere JE; Anderson VL
    Am J Vet Res; 1986 Apr; 47(4):789-94. PubMed ID: 3963580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gentamicin concentrations in synovial fluid and joint tissues during intravenous administration or continuous intra-articular infusion of the tarsocrural joint of clinically normal horses.
    Lescun TB; Ward MP; Adams SB
    Am J Vet Res; 2006 Mar; 67(3):409-16. PubMed ID: 16506901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
    Mansur JM; Abramowitz PW; Lerner SA; Smith RB; Townsend RJ
    Am J Hosp Pharm; 1985 Feb; 42(2):332-5. PubMed ID: 3976680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronopharmacokinetic study of gentamicin in dogs.
    Widerhon N; Díaz D; Picco E; Rebuelto M; Encinas T; Carlos Boggio J
    Chronobiol Int; 2005; 22(4):731-9. PubMed ID: 16147903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
    de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
    J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of product drying performance in molded and serum tubing vials using gentamicin sulfate as a model system.
    Hibler S; Wagner C; Gieseler H
    Pharm Dev Technol; 2012; 17(5):541-51. PubMed ID: 22734495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled release infusion kinetics of tobramycin.
    Lane JR; Murray WE; Willenborg NL; Wilcox CL; Connor JD; Adler DS
    Ther Drug Monit; 1989; 11(3):264-8. PubMed ID: 2728084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Method for evaluating drip-rate accuracy of intravenous flow-regulating devices.
    Carleton BC; Cipolle RJ; Larson SD; Canafax DM
    Am J Hosp Pharm; 1991 Nov; 48(11):2422-6. PubMed ID: 1746576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inline fluid dynamics in piggyback and manifold drug delivery systems.
    Leissing NC; Story KO; Zaske D
    Am J Hosp Pharm; 1989 Jan; 46(1):89-97. PubMed ID: 2712034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost evaluation of a new iv device in an Israeli hospital.
    Lustig A
    Eur J Clin Pharmacol; 1994; 47(2):203-6. PubMed ID: 7859810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of gentamicin after i.v. infusion or iv bolus.
    Meunier F; Van der Auwera P; Schmitt H; de Maertelaer V; Klastersky J
    J Antimicrob Chemother; 1987 Feb; 19(2):225-31. PubMed ID: 3571043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to letter on i.v. infusions of gentamicin and ampicillin.
    Geyer J
    Pediatr Nurs; 1989; 15(5):514-5. PubMed ID: 2587110
    [No Abstract]   [Full Text] [Related]  

  • 60. Gentamicin intravenous infusion rate: effect on interstitial fluid concentration.
    Kozak AJ; Gerding DN; Peterson LR; Hall WH
    Antimicrob Agents Chemother; 1977 Nov; 12(5):606-8. PubMed ID: 921257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.